Biriperone-d4

CAS: 42021-34-1

Ref. 3D-SBA02134

Información del producto

• Nombre: Biriperone-d4
• Sinónimos: (1)-1-(4-Fluorophenyl)-4-(3,4,6,7,12,12a-hexahydropyrazino(1',2':1,6)pyrido(3,4-b)indol-2(1H)-yl)butan-1-one, 1-(4-Fluorophenyl)-4-(3,4,12,12a-tetrahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indol-2(1H,6H,7H)-yl)butan-1-one, 1-(4-Fluorophenyl)-4-(3,4,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indol-2(1H)-yl)-1-butanone, 1-Butanone, 1-(4-fluorophenyl)-4-(3,4,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indol-2(1H)-yl)-, 2-[4-(4-Fluorophenyl)-4-oxobutyl]-1,2,3,4,6,7,12,12a-octahydropyrazino[2′,1′:6,1]pyrido[3,4-b]indole, Biriperone, Centbutindole, NSC 143691, Pyrazino(1',2':1,6)pyrido(3,4-b)indole, 1,2,3,4,6,7,12,12a-octahydro-2-(3-(p-fluorobenzoyl)propyl)-, dl-, Pyrazino[1′,2′:1,6]pyrido[3,4-b]indole, 1-butanone deriv.
• CAS: 42021-34-1

Descripción

Biriperone-d4 is a pharmaceutical drug that belongs to the class of dopamine receptor antagonists. It is an analog of the neurotransmitter dopamine and acts as a competitive antagonist at both 5-HT1 and 5-HT2 receptors. Biriperone-d4 has been shown to reduce symptoms in patients with inflammatory bowel disease, including diarrhea, abdominal pain, weight loss, and rectal bleeding. This drug also exhibits anti-inflammatory effects by inhibiting the production of proinflammatory cytokines such as IL-6 and TNFα. Biriperone-d4 is rapidly absorbed when given orally and undergoes extensive first pass metabolism before being eliminated through the kidneys. The elimination half life is approximately 2 hours.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 391.5 g/mol
• Fórmula: C₂₄H₂₆FN₃O
• Pureza: Min. 95%